Actieve functies van Christine Guillen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ELSALYS BIOTECH | Directeur/Bestuurslid | 01-01-2013 | - |
Algemeen Directeur | 01-01-2013 | - | |
Oprichter | 01-01-2013 | - |
Loopbaan van Christine Guillen
Eerdere bekende functies van Christine Guillen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
TRANSGENE | Corporate Officer/Principal | 01-11-2007 | 01-01-2013 |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Corporate Officer/Principal | 01-05-2005 | 01-10-2007 |
Statistieken
Internationaal
Frankrijk | 4 |
Operationeel
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TRANSGENE | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
ElsaLys Biotech SAS
ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Health Technology |
- Beurs
- Insiders
- Christine Guillen
- Ervaring